J. Steenkamer

Fibrostenotic Phenotype of Myofibroblasts in Crohn’s Disease is Dependent on Tissue Stiffness and Reversed by LOX Inhibition

C. Buskens, W. Bemelman, G. D'Haens, 2017, Journal of Crohn's & colitis.

Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease

C. Buskens, W. Bemelman, C. Ponsioen, 2018, PloS one.